These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 16478775

  • 1. Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance.
    Muscelli E, Mari A, Natali A, Astiarraga BD, Camastra S, Frascerra S, Holst JJ, Ferrannini E.
    Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1144-50. PubMed ID: 16478775
    [Abstract] [Full Text] [Related]

  • 2. Value of the intravenous and oral glucose tolerance tests for detecting subtle impairments in insulin sensitivity and beta-cell function in former gestational diabetes.
    Tura A, Mari A, Prikoszovich T, Pacini G, Kautzky-Willer A.
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):237-43. PubMed ID: 18194489
    [Abstract] [Full Text] [Related]

  • 3. Beta-cell function and insulin sensitivity contribute to the shape of plasma glucose curve during an oral glucose tolerance test in non-diabetic individuals.
    Kanauchi M, Kimura K, Kanauchi K, Saito Y.
    Int J Clin Pract; 2005 Apr; 59(4):427-32. PubMed ID: 15853859
    [Abstract] [Full Text] [Related]

  • 4. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
    Pacini G, Thomaseth K, Ahrén B.
    Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002
    [Abstract] [Full Text] [Related]

  • 5. Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy.
    Andersen O, Haugaard SB, Holst JJ, Deacon CF, Iversen J, Andersen UB, Nielsen JO, Madsbad S.
    HIV Med; 2005 Mar; 6(2):91-8. PubMed ID: 15807714
    [Abstract] [Full Text] [Related]

  • 6. Improved tolerance to sequential glucose loading (Staub-Traugott effect): size and mechanisms.
    Bonuccelli S, Muscelli E, Gastaldelli A, Barsotti E, Astiarraga BD, Holst JJ, Mari A, Ferrannini E.
    Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E532-7. PubMed ID: 19531643
    [Abstract] [Full Text] [Related]

  • 7. Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance.
    Rosenstock J, Foley JE, Rendell M, Landin-Olsson M, Holst JJ, Deacon CF, Rochotte E, Baron MA.
    Diabetes Care; 2008 Jan; 31(1):30-5. PubMed ID: 17947341
    [Abstract] [Full Text] [Related]

  • 8. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
    Nauck MA, El-Ouaghlidi A, Gabrys B, Hücking K, Holst JJ, Deacon CF, Gallwitz B, Schmidt WE, Meier JJ.
    Regul Pept; 2004 Nov 15; 122(3):209-17. PubMed ID: 15491793
    [Abstract] [Full Text] [Related]

  • 9. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
    Vollmer K, Holst JJ, Baller B, Ellrichmann M, Nauck MA, Schmidt WE, Meier JJ.
    Diabetes; 2008 Mar 15; 57(3):678-87. PubMed ID: 18057091
    [Abstract] [Full Text] [Related]

  • 10. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E, Menschikowski M, Koehler C, Leonhardt W, Hanefeld M.
    Metabolism; 2005 Sep 15; 54(9):1168-73. PubMed ID: 16125528
    [Abstract] [Full Text] [Related]

  • 11. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
    Rask E, Olsson T, Söderberg S, Holst Jj Jj, Tura A, Pacini G, Ahrén B.
    Metabolism; 2004 May 15; 53(5):624-31. PubMed ID: 15131768
    [Abstract] [Full Text] [Related]

  • 12. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
    Knop FK, Aaboe K, Vilsbøll T, Vølund A, Holst JJ, Krarup T, Madsbad S.
    Diabetes Obes Metab; 2012 Jun 15; 14(6):500-10. PubMed ID: 22171657
    [Abstract] [Full Text] [Related]

  • 13. Basal and dynamic proinsulin-insulin relationship to assess beta-cell function during OGTT in metabolic disorders.
    Tura A, Pacini G, Kautzky-Willer A, Ludvik B, Prager R, Thomaseth K.
    Am J Physiol Endocrinol Metab; 2003 Jul 15; 285(1):E155-62. PubMed ID: 12670835
    [Abstract] [Full Text] [Related]

  • 14. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
    Qian L, Fu X, Xu L, Zheng S, Zhou W, Wang X, Gu Y, Lin F, Luo M.
    Clin Endocrinol (Oxf); 2008 Oct 15; 69(4):575-9. PubMed ID: 18248638
    [Abstract] [Full Text] [Related]

  • 15. Older Subjects With β-Cell Dysfunction Have an Accentuated Incretin Release.
    de Jesús Garduno-Garcia J, Gastaldelli A, DeFronzo RA, Lertwattanarak R, Holst JJ, Musi N.
    J Clin Endocrinol Metab; 2018 Jul 01; 103(7):2613-2619. PubMed ID: 29672742
    [Abstract] [Full Text] [Related]

  • 16. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N, Hara K, Yatsuka C, Nakano T, Matsumoto S, Suetsugu M, Nakamachi T, Takebayashi K, Inukai T, Haruki K, Aso Y.
    Metabolism; 2009 Oct 01; 58(10):1470-6. PubMed ID: 19592051
    [Abstract] [Full Text] [Related]

  • 17. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.
    Rijkelijkhuizen JM, Doesburg T, Girman CJ, Mari A, Rhodes T, Gastaldelli A, Nijpels G, Dekker JM.
    Metabolism; 2009 Feb 01; 58(2):196-203. PubMed ID: 19154952
    [Abstract] [Full Text] [Related]

  • 18. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
    Tura A, Bagger JI, Ferrannini E, Holst JJ, Knop FK, Vilsbøll T, Mari A.
    Nutr Metab Cardiovasc Dis; 2017 Dec 01; 27(12):1123-1129. PubMed ID: 29162361
    [Abstract] [Full Text] [Related]

  • 19. Classical and model-based estimates of beta-cell function during a mixed meal vs. an OGTT in a population-based cohort.
    Rijkelijkhuizen JM, Girman CJ, Mari A, Alssema M, Rhodes T, Nijpels G, Kostense PJ, Stein PP, Eekhoff EM, Heine RJ, Dekker JM.
    Diabetes Res Clin Pract; 2009 Feb 01; 83(2):280-8. PubMed ID: 19097663
    [Abstract] [Full Text] [Related]

  • 20. [Application of hyperglycemic clamp technique in the assessment of beta-cell function in obese individuals with glucose intolerance].
    Bao YQ, Jia WP, Zhu M, Lu JX, Chen L, Xiang KS.
    Zhonghua Yi Xue Za Zhi; 2004 Nov 02; 84(21):1781-4. PubMed ID: 15631773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.